Firefly Neuroscience, Inc.
AIFF
$1.73
$0.052.98%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 958.11% | 568.75% | -72.48% | -78.31% | -84.55% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 958.11% | 568.75% | -72.48% | -78.31% | -84.55% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 597.30% | 529.69% | -72.48% | -78.31% | -84.55% |
| SG&A Expenses | 14.97% | 149.97% | 158.34% | 158.69% | 273.15% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 14.40% | 135.67% | 149.35% | 159.73% | 188.47% |
| Operating Income | -5.86% | -129.60% | -180.26% | -198.25% | -243.33% |
| Income Before Tax | -173.27% | -455.23% | -602.18% | -302.85% | -218.05% |
| Income Tax Expenses | 500.00% | 500.00% | 100.00% | 100.00% | -- |
| Earnings from Continuing Operations | -173.31% | -455.24% | -602.02% | -302.77% | -218.10% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -173.31% | -455.24% | -602.02% | -302.77% | -218.10% |
| EBIT | -5.86% | -129.60% | -180.26% | -198.25% | -243.33% |
| EBITDA | -21.42% | -201.73% | -301.55% | -163.67% | -198.48% |
| EPS Basic | -85.40% | -215.25% | -335.75% | -194.97% | -136.69% |
| Normalized Basic EPS | -43.84% | -156.16% | -257.46% | -175.09% | -112.71% |
| EPS Diluted | -85.40% | -215.25% | -335.75% | -194.97% | -136.69% |
| Normalized Diluted EPS | -43.84% | -156.16% | -257.46% | -175.09% | -112.71% |
| Average Basic Shares Outstanding | 111.91% | 116.37% | -35.33% | -56.91% | -64.52% |
| Average Diluted Shares Outstanding | 111.91% | 116.37% | -35.33% | -56.91% | -64.52% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |